Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Bladder Cancer

  Free Subscription


30.09.2019

1 Aging (Albany NY)
1 Biochem Biophys Res Commun
1 Case Rep Oncol
1 Clin Ther
1 Eur J Surg Oncol
1 Eur Urol Focus
1 Exp Ther Med
1 Front Immunol
2 Front Oncol
3 Int Braz J Urol
2 Int J Mol Med
1 J Cancer Res Clin Oncol
1 J Clin Med
1 J Comput Biol
1 J Urol
1 JAMA
1 Nat Commun
1 Pol J Pathol
1 Scand J Urol
1 Technol Cancer Res Treat
1 Urologe A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Aging (Albany NY)

  1. SHAN L, Liu W, Zhan Y
    Sulfated polysaccharide of Sepiella maindroni ink targets Akt and overcomes resistance to the FGFR inhibitor AZD4547 in bladder cancer.
    Aging (Albany NY). 2019;11.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  2. HOU G, Xu W, Jin Y, Wu J, et al
    MiRNA-217 accelerates the proliferation and migration of bladder cancer via inhibiting KMT2D.
    Biochem Biophys Res Commun. 2019 Sep 20. pii: S0006-291X(19)31750.
    PubMed     Text format     Abstract available


    Case Rep Oncol

  3. MORINAGA R, Kawahara T, Kuroda S, Inayama Y, et al
    Granulocyte Colony-Stimulating Factor-Producing Bladder Cancer.
    Case Rep Oncol. 2019;12:603-607.
    PubMed     Text format     Abstract available


    Clin Ther

  4. BHUSHAN S, Ray RS, Prakash J, Singh GN, et al
    Global Versus Indian Perspective of Pioglitazone-induced Adverse Drug Reactions Including Bladder Cancer: A Comparative Retrospective Pharmacovigilance Analysis.
    Clin Ther. 2019 Sep 19. pii: S0149-2918(19)30422.
    PubMed     Text format     Abstract available


    Eur J Surg Oncol

  5. HU X, Xiong SC, Dou WC, Shao YX, et al
    Minimally invasive vs open radical cystectomy in patients with bladder cancer: A systematic review and meta-analysis of randomized controlled trials.
    Eur J Surg Oncol. 2019 Sep 13. pii: S0748-7983(19)30808.
    PubMed     Text format     Abstract available


    Eur Urol Focus

  6. BOCHNER BH
    Lymph Node Dissection for Advanced Bladder Cancer: Is There a Role?
    Eur Urol Focus. 2019 Sep 21. pii: S2405-4569(19)30284.
    PubMed     Text format     Abstract available


    Exp Ther Med

  7. ZHANG Z, Xu H, Ji J, Shi X, et al
    Heterogeneity of PTEN and PPAR-gamma in cancer and their prognostic application to bladder cancer.
    Exp Ther Med. 2019;18:3177-3183.
    PubMed     Text format     Abstract available


    Front Immunol

  8. DAZA-CAJIGAL V, Albuquerque AS, Pearson J, Hinley J, et al
    Loss of Janus Associated Kinase 1 Alters Urothelial Cell Function and Facilitates the Development of Bladder Cancer.
    Front Immunol. 2019;10:2065.
    PubMed     Text format     Abstract available


    Front Oncol

  9. ABUDUREXITI M, Xie H, Jia Z, Zhu Y, et al
    Development and External Validation of a Novel 12-Gene Signature for Prediction of Overall Survival in Muscle-Invasive Bladder Cancer.
    Front Oncol. 2019;9:856.
    PubMed     Text format     Abstract available

  10. DATTA NR, Stutz E, Puric E, Eberle B, et al
    A Pilot Study of Radiotherapy and Local Hyperthermia in Elderly Patients With Muscle-Invasive Bladder Cancers Unfit for Definitive Surgery or Chemoradiotherapy.
    Front Oncol. 2019;9:889.
    PubMed     Text format     Abstract available


    Int Braz J Urol

  11. MOSCHINI M, Stabile A, Mattei A, Montorsi F, et al
    Enhanced recovery after surgery (ERAS) in radical cystectomy patients: from consensus to evidences.
    Int Braz J Urol. 2019;45:655-657.
    PubMed     Text format    

  12. BASATAC C, Aktepe F, Saglam S, Akpinar H, et al
    Synchronous presentation of muscle-invasive urothelial carcinoma of bladder and peritoneal malign mesothelioma.
    Int Braz J Urol. 2019;45:843-846.
    PubMed     Text format     Abstract available

  13. CASTELLANI D, Gasparri L, Claudini R, Pavia MP, et al
    Iatrogenic foreign body in urinary bladder: Holmium laser vs. Ceramic, and the winner is....
    Int Braz J Urol. 2019;45:853.
    PubMed     Text format     Abstract available


    Int J Mol Med

  14. YANG C, Sun X, Wang H, Lu T, et al
    Metabolomic profiling identifies novel biomarkers and mechanisms in human bladder cancer treated with submucosal injection of gemcitabine.
    Int J Mol Med. 2019 Sep 23. doi: 10.3892/ijmm.2019.4347.
    PubMed     Text format     Abstract available

  15. LI W, Li Y, Sun Z, Zhou J, et al
    Comprehensive circular RNA profiling reveals the regulatory role of the hsa_circ_0137606/miR1231 pathway in bladder cancer progression.
    Int J Mol Med. 2019 Sep 17. doi: 10.3892/ijmm.2019.4340.
    PubMed     Text format     Abstract available


    J Cancer Res Clin Oncol

  16. BAUMGART S, Meschkat P, Edelmann P, Heinzelmann J, et al
    MicroRNAs in tumor samples and urinary extracellular vesicles as a putative diagnostic tool for muscle-invasive bladder cancer.
    J Cancer Res Clin Oncol. 2019 Sep 24. pii: 10.1007/s00432-019-03035.
    PubMed     Text format     Abstract available


    J Clin Med

  17. JANISCH F, Yu H, Vetterlein MW, Dahlem R, et al
    Do Younger Patients with Muscle-Invasive Bladder Cancer have Better Outcomes?
    J Clin Med. 2019;8.
    PubMed     Text format     Abstract available


    J Comput Biol

  18. LIU Y, Xiong S, Liu S, Chen J, et al
    Analysis of Gene Expression in Bladder Cancer: Possible Involvement of Mitosis and Complement and Coagulation Cascades Signaling Pathway.
    J Comput Biol. 2019 Sep 23. doi: 10.1089/cmb.2019.0237.
    PubMed     Text format     Abstract available


    J Urol

  19. LIEM EI, Oddens JR, Vernooij R, Li R, et al
    The Role of Fluorescence in Situ Hybridization for Predicting Recurrence after Adjuvant Bacillus Calmette-Guerin in Intermediate- and High-Risk Non-muscle Invasive Bladder Cancer Patients: A Systematic Review and Meta-Analysis of Individual Patient Da
    J Urol. 2019 Sep 24:101097JU0000000000000566. doi: 10.1097/JU.0000000000000566.
    PubMed     Text format     Abstract available


    JAMA

  20. PARIKH RB, Adamson BJS, Khozin S, Galsky MD, et al
    Association Between FDA Label Restriction and Immunotherapy and Chemotherapy Use in Bladder Cancer.
    JAMA. 2019;322:1209-1211.
    PubMed     Text format    


    Nat Commun

  21. SIM WJ, Iyengar PV, Lama D, Lui SKL, et al
    c-Met activation leads to the establishment of a TGFbeta-receptor regulatory network in bladder cancer progression.
    Nat Commun. 2019;10:4349.
    PubMed     Text format     Abstract available


    Pol J Pathol

  22. NESI G, Galli IC, Amorosi A, Santi R, et al
    Environment and urinary bladder cancer. A historical perspective.
    Pol J Pathol. 2019;70:21-25.
    PubMed     Text format     Abstract available


    Scand J Urol

  23. KLEN R, Salminen AP, Mahmoudian M, Syvanen KT, et al
    Prediction of complication related death after radical cystectomy for bladder cancer with machine learning methodology.
    Scand J Urol. 2019 Sep 25:1-7. doi: 10.1080/21681805.2019.1665579.
    PubMed     Text format     Abstract available


    Technol Cancer Res Treat

  24. LUO Y, Dong Y, Liang S, Yuan L, et al
    CpG Oligodeoxynucleotide Promotes Apoptosis of Human Bladder Cancer T24 Cells Via Inhibition of the Antiapoptotic Factors.
    Technol Cancer Res Treat. 2019;18:1533033819873636.
    PubMed     Text format     Abstract available


    Urologe A

  25. ORTIZ-BRUCHLE N, Muders M, Toma M, Esposito I, et al
    [Status of the availability and use of next generation sequencing (NGS) in bladder cancer-a questionnaire within the uropathology working group].
    Urologe A. 2019 Sep 20. pii: 10.1007/s00120-019-01046.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: